Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by remarkable toxicity and great variability in response to treatment. Plenteous pharmacogenetic studies have already been published for classical therapies, such as cytarabine or anthracyclines, but such studies remain scarce for...
Saved in:
Main Authors: | Álvaro Pinto-Merino (Author), Jorge Labrador (Author), Pablo Zubiaur (Author), Raquel Alcaraz (Author), María José Herrero (Author), Pau Montesinos (Author), Francisco Abad-Santos (Author), Miriam Saiz-Rodríguez (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
by: Juan Eduardo Megías-Vericat, et al.
Published: (2022) -
Association Studies in Clinical Pharmacogenetics
by: Pablo Zubiaur, et al.
Published: (2022) -
The Pharmacogenetics of Treatment with Quetiapine
by: María Ortega-Ruiz, et al.
Published: (2022) -
Immunotherapies for Acute Myeloid Leukemia
Published: (2020) -
Myeloid sarcoma on the scalp of a patient with acute myeloid leukemia
by: Débora Nogueira Muniz, et al.
Published: (2019)